Skip to main content
Erschienen in: Medical Oncology 7/2016

01.07.2016 | Original Paper

Use of complementary and alternative medicine by patients with cancer: a cross-sectional study at different points of cancer care

verfasst von: J. Kleine Wortmann, A. Bremer, HT Eich, HP Kleine Wortmann, A. Schuster, J. Fühner, J. Büntzel, R. Muecke, FJ Prott, J. Huebner

Erschienen in: Medical Oncology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Complementary and alternative medicine (CAM) is widely used by cancer patients. In order to learn more on the usage of CAM, its reasons and motifs as well as sources of information along the trajectory of treatment, we decided to evaluate the prevalence and predictors for the use of CAM by cancer patients while being under active treatment with chemo- or radiotherapy or in aftercare. We distributed a standardized questionnaire among patients attending a department of radio-oncology, an ambulance for oncology and offices of general practitioners (GPs). Five hundred and six patients took part. Most attributed cancer to stress and trauma (23.7 and 16.4 %) or genes (20.8 %). Forty-four percentage reported knowing a physician with competence in CAM, and in all settings, most patients named the GP. Fifty-one percentage admitted using CAM, 35 % informed the oncologist about using CAM, 56 % informed the GP, and 26 % did not inform any physician. Most often used CAM was vitamin D (17 %) and selenium (16 %). Most important goals were to strengthen the immune system (59 %) and become active (52 %). Most patients were satisfied with the CAM methods they used. Yet, with some methods, dissatisfaction was up to 30 %. The GP has an important function concerning CAM in oncology as most patients believe the GP to have best knowledge in CAM. In order to integrate complementary medicine into evidence-based medicine, physicians should be trained on how to communicate on CAM with the patient and with each other. Explaining cancer and cancer therapies in a way lay persons are able to understand may be helpful. Physicians should actively address patients’ needs of involvement not only in decision making, but also actively in the therapy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Eardley S, Bishop FL, Prescott P, et al. A systematic literature review of complementary and alternative medicine prevalence in EU. Forsch Komplementärmedizin Res Complement Med. 2012;19(s2):18–28.CrossRef Eardley S, Bishop FL, Prescott P, et al. A systematic literature review of complementary and alternative medicine prevalence in EU. Forsch Komplementärmedizin Res Complement Med. 2012;19(s2):18–28.CrossRef
2.
Zurück zum Zitat Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16:655–63.CrossRefPubMed Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16:655–63.CrossRefPubMed
3.
Zurück zum Zitat Horneber M, Bueschel G, Dennert G, et al. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11(3):187–203.CrossRefPubMed Horneber M, Bueschel G, Dennert G, et al. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther. 2012;11(3):187–203.CrossRefPubMed
4.
Zurück zum Zitat Micke O, Bruns F, Glatzel M, et al. Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integr Med. 2009;1:22–30. Micke O, Bruns F, Glatzel M, et al. Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integr Med. 2009;1:22–30.
5.
Zurück zum Zitat Huebner J, Micke O, Muecke R, et al. User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center. Anticancer Res. 2014;34:943–8.PubMed Huebner J, Micke O, Muecke R, et al. User rate of complementary and alternative medicine (CAM) of patients visiting a counseling facility for CAM of a German comprehensive cancer center. Anticancer Res. 2014;34:943–8.PubMed
6.
Zurück zum Zitat Muenstedt K, Duetemeyer V, Huebner J. Patients’ considerations behind the use of methods from complementary and alternative medicine in the field of obstetrics in Germany. Arch Gynecol Obstet. 2013;288(3):527–30.CrossRef Muenstedt K, Duetemeyer V, Huebner J. Patients’ considerations behind the use of methods from complementary and alternative medicine in the field of obstetrics in Germany. Arch Gynecol Obstet. 2013;288(3):527–30.CrossRef
7.
Zurück zum Zitat Huebner J, Muenstedt K, Prott FJ, et al. Online survey of patients with breast cancer on complementary and alternative medicine. Breast Care. 2014;9(1):60–3.CrossRefPubMedPubMedCentral Huebner J, Muenstedt K, Prott FJ, et al. Online survey of patients with breast cancer on complementary and alternative medicine. Breast Care. 2014;9(1):60–3.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Ott IM, Muenstedt K, Micke O, et al. Attitude of oncology/haematology nurses from German speaking countries towards complementary and alternative medicine. Trace Elem Electrolyt. 2015;32(2):74–80.CrossRef Ott IM, Muenstedt K, Micke O, et al. Attitude of oncology/haematology nurses from German speaking countries towards complementary and alternative medicine. Trace Elem Electrolyt. 2015;32(2):74–80.CrossRef
9.
Zurück zum Zitat Conrad C, Muenstedt K, Micke O, et al. Survey of members of the German society for palliative medicine regarding their attitudes towards complementary and alternative medicine for cancer patients. J Cancer Res Clin Oncol. 2014;140(7):1229–37.CrossRefPubMed Conrad C, Muenstedt K, Micke O, et al. Survey of members of the German society for palliative medicine regarding their attitudes towards complementary and alternative medicine for cancer patients. J Cancer Res Clin Oncol. 2014;140(7):1229–37.CrossRefPubMed
10.
Zurück zum Zitat Trimborn A, Senf B, Muenstedt K, Buentzel J, et al. Attitude of employees of a university clinic to complementary and alternative medicine in oncology. Ann Oncol. 2013;24(10):2641–5.CrossRefPubMed Trimborn A, Senf B, Muenstedt K, Buentzel J, et al. Attitude of employees of a university clinic to complementary and alternative medicine in oncology. Ann Oncol. 2013;24(10):2641–5.CrossRefPubMed
11.
Zurück zum Zitat Eschiti VS. Lesson from comparison of CAM use by women with female-specific cancers to others: it‘s time to focus on interaction risks with CAM therapies. Integrat Cancer Ther. 2007;6(4):313–44.CrossRef Eschiti VS. Lesson from comparison of CAM use by women with female-specific cancers to others: it‘s time to focus on interaction risks with CAM therapies. Integrat Cancer Ther. 2007;6(4):313–44.CrossRef
12.
Zurück zum Zitat Buessing A, Cysarz D, Edelhäuser F. Inanspruchnahme unterstützender komplementärmedizinischer Verfahren bei Tumorpatienten in der späteren Phase. Deutsche Zeitschrift für Onkologie. 2007;39:162–8.CrossRef Buessing A, Cysarz D, Edelhäuser F. Inanspruchnahme unterstützender komplementärmedizinischer Verfahren bei Tumorpatienten in der späteren Phase. Deutsche Zeitschrift für Onkologie. 2007;39:162–8.CrossRef
13.
Zurück zum Zitat Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505–14.PubMed Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505–14.PubMed
14.
Zurück zum Zitat Paul M, Davey B, Senf B, et al. Patients with advanced cancer and their usage of complementary and alternative medicine. J Cancer Res Clin Oncol. 2013;130(9):1515–22.CrossRef Paul M, Davey B, Senf B, et al. Patients with advanced cancer and their usage of complementary and alternative medicine. J Cancer Res Clin Oncol. 2013;130(9):1515–22.CrossRef
15.
Zurück zum Zitat Zeller T, Muenstedt K, Stoll C, et al. Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol. 2013;139:357–65.CrossRefPubMed Zeller T, Muenstedt K, Stoll C, et al. Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol. 2013;139:357–65.CrossRefPubMed
16.
Zurück zum Zitat Klafke N, Eliott JA, Wittert GA, Olver IN. Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient services. Ann Oncol. 2012;23:1571–8.CrossRefPubMed Klafke N, Eliott JA, Wittert GA, Olver IN. Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient services. Ann Oncol. 2012;23:1571–8.CrossRefPubMed
17.
Zurück zum Zitat Huebner J, Prott FJ, Micke O, Muecke R, Senf B, Dennert G, Muenstedt K. Online survey of cancer patients on complementary and alternative medicine. Oncol Res Treat. 2014;37:304–8.CrossRefPubMed Huebner J, Prott FJ, Micke O, Muecke R, Senf B, Dennert G, Muenstedt K. Online survey of cancer patients on complementary and alternative medicine. Oncol Res Treat. 2014;37:304–8.CrossRefPubMed
18.
Zurück zum Zitat Chrystal K, Allan S, Forgeson C, Issacs R. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J. 2003;116(1168):U296.PubMed Chrystal K, Allan S, Forgeson C, Issacs R. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J. 2003;116(1168):U296.PubMed
19.
Zurück zum Zitat Linke B, Liebl P, Marten D, Stoll C, Jung B, Wuensch P, Huebner J. Information concerning endocrine therapy and adherence of patients with breast and prostate cancer. Clin Oncol (R Coll Radiol). 2015;27(8):482–3.CrossRef Linke B, Liebl P, Marten D, Stoll C, Jung B, Wuensch P, Huebner J. Information concerning endocrine therapy and adherence of patients with breast and prostate cancer. Clin Oncol (R Coll Radiol). 2015;27(8):482–3.CrossRef
20.
Zurück zum Zitat Vapiwala N, Mick R, Hampshire MK, Metz JM, DeNittis AS. Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J. 2006;12(6):467–74.CrossRefPubMed Vapiwala N, Mick R, Hampshire MK, Metz JM, DeNittis AS. Patient initiation of complementary and alternative medical therapies (CAM) following cancer diagnosis. Cancer J. 2006;12(6):467–74.CrossRefPubMed
21.
Zurück zum Zitat Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler K, Kurschat P, et al. Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma. Med Oncol. 2016;33(5):52. doi:10.1007/s12032-016-0764-6. Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler K, Kurschat P, et al. Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma. Med Oncol. 2016;33(5):52. doi:10.​1007/​s12032-016-0764-6.
22.
Zurück zum Zitat Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler K, Kurschat P, et al. Interactions from complementary and alternative medicine in patients with melanoma-a survey of 1097 patients. Submitt. Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler K, Kurschat P, et al. Interactions from complementary and alternative medicine in patients with melanoma-a survey of 1097 patients. Submitt.
23.
Zurück zum Zitat Huebner J, Muenstedt K, Muecke R, Micke O, Stoll C, Kleeberg UR, Buentzel J, Dennert G. Prott FJ counseling cancer patients on complementary and alternative medicine. Strahlenther Onkol. 2013;189(8):613–7.CrossRef Huebner J, Muenstedt K, Muecke R, Micke O, Stoll C, Kleeberg UR, Buentzel J, Dennert G. Prott FJ counseling cancer patients on complementary and alternative medicine. Strahlenther Onkol. 2013;189(8):613–7.CrossRef
Metadaten
Titel
Use of complementary and alternative medicine by patients with cancer: a cross-sectional study at different points of cancer care
verfasst von
J. Kleine Wortmann
A. Bremer
HT Eich
HP Kleine Wortmann
A. Schuster
J. Fühner
J. Büntzel
R. Muecke
FJ Prott
J. Huebner
Publikationsdatum
01.07.2016
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 7/2016
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-016-0790-4

Weitere Artikel der Ausgabe 7/2016

Medical Oncology 7/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.